Page 187 - 2019_10 resto del Mondo_web

BCL2L2 promotes MK numbers and PPF
14. Edelstein LC, Simon LM, Montoya RT, et al. Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c. Nat Med. 2013;19(12):1609-1616.
15. Faraday N, Rade JJ, Johns DC, et al. Ex vivo cultured megakaryocytes express functional glycoprotein IIb-IIIa receptors and are capa- ble of adenovirus-mediated transgene expression. Blood. 1999;94(12):4084-4092.
16. Bergmeier W, Burger PC, Piffath CL, et al. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood. 2003;102(12):4229-4235.
17. Sim X, Jarocha D, Hayes V, et al. Identifying and enriching the platelet-producing human stem cell-derived megakaryocytes using factor V uptake. Blood. 2017;130(2):192- 204.
18. Parish CR. Fluorescent dyes for lymphocyte migration and proliferation studies. Immunol Cell Biol. 1999;77(6):499-508.
19. Ragnarson B, Bengtsson L, Haegerstrand A. Labeling with fluorescent carbocyanine dyes of cultured endothelial and smooth muscle cells by growth in dye-containing medium. Histochemistry. 1992;97(4):329-333.
20. Mason KD, Carpinelli MR, Fletcher JI, et al. Programmed anuclear cell death delimits platelet life span. Cell. 2007;128(6):1173- 1186.
21. Beauchemin H, Shooshtarizadeh P, Vadnais C, Vassen L, Pastore YD, Moroy T. Gfi1b controls integrin signaling-dependent cytoskeleton dynamics and organization in megakaryocytes. Haematologica. 2017;102 (3):484-497.
22. Machlus KR, Johnson KE, Kulenthirarajan R, et al. CCL5 derived from platelets increases megakaryocyte proplatelet formation. Blood. 2016;127(7):921-926.
23. Thon JN, Mazutis L, Wu S, et al. Platelet bioreactor-on-a-chip. Blood. 2014; 124(12): 1857-1867.
24. Sugimoto N, Eto K. Platelet production from induced pluripotent stem cells. J Thromb Haemost. 2017;15(9):1717-1727.
25. McArthur K, Chappaz S, Kile BT. Apoptosis in megakaryocytes and platelets: the life and death of a lineage. Blood. 2018;131(6):605- 610.
26. Schoenwaelder SM, Jarman KE, Gardiner EE, et al. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy
that undermines the hemostatic function of
platelets. Blood. 2011;118(6):1663-1674.
27. White MJ, Schoenwaelder SM, Josefsson EC, et al. Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and func-
tion. Blood. 2012;119(18):4283-4290.
28. Cramer EM, Norol F, Guichard J, et al. Ultrastructure of platelet formation by human megakaryocytes cultured with the
Mpl ligand. Blood. 1997;89(7):2336-2346. 29. Bellanne-Chantelot C, Schmaltz-Panneau B, Marty C, et al. Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.
Blood. 2018;132(12):1318-1331.
30. Radley JM, Haller CJ. Fate of senescent
megakaryocytes in the bone marrow. Br J
Haematol. 1983;53(2):277-287.
31. Alberio L, Safa O, Clemetson KJ, Esmon CT,
Dale GL. Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood. 2000;95(5):1694-1702.
32. Dale GL, Friese P, Batar P, et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature. 2002;415(6868):175- 179.
33. Jobe SM, Leo L, Eastvold JS, et al. Role of FcRgamma and factor XIIIA in coated platelet formation. Blood. 2005; 106(13): 4146-4151.
34. Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW, Adams JM. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci U S A. 1999;96(26):14943-14948.
35. Debrincat MA, Pleines I, Lebois M, et al. BCL-2 is dispensable for thrombopoiesis and platelet survival. Cell Death Dis. 2015;6:e1721.
36. Print CG, Loveland KL, Gibson L, et al. Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc Natl Acad Sci U S A. 1998; 95(21):12424-12431.
37. Rowley JW, Oler AJ, Tolley ND, et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood. 2011;118(14):e101-111.
38. Balduini A, Pallotta I, Malara A, et al.
Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet for- mation by human megakaryocytes. J Thromb Haemost. 2008;6(11):1900-1907.
39. Caparros-Perez E, Teruel-Montoya R, Lopez-Andreo MJ, et al. Comprehensive comparison of neonate and adult human platelet transcriptomes. PLoS One. 2017; 12(8):e0183042.
40. Simon LM, Edelstein LC, Nagalla S, et al. Human platelet microRNA-mRNA net- works associated with age and gender revealed by integrated plateletomics. Blood. 2014;123(16):e37-45.
41. Oltersdorf T, Elmore SW, Shoemaker AR, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005;435(7042):677-681.
42. Roberts AW, Seymour JF, Brown JR, et al. Substantial susceptibility of chronic lym- phocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease. J Clin Oncol. 2012;30(5):488-496.
43. Wilson WH, O'Connor OA, Czuczman MS, et al. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignan- cies: a phase 1 dose-escalation study of safe- ty, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol. 2010; 11(12):1149-1159.
44. De Blasio A, Vento R, Di Fiore R. Mcl-1 tar- geting could be an intriguing perspective to cure cancer. J Cell Physiol. 2018; 233(11):8482-8498.
45. Beroukhim R, Mermel CH, Porter D, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010;463(7283):899-905.
46. Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5): 401-404.
47. Malara A, Fresia C, Di Buduo CA, et al. The Plant Hormone Abscisic Acid Is a Prosurvival Factor in Human and Murine Megakaryocytes. J Biol Chem. 2017;292 (8):3239-3251.
48. Strassel C, Brouard N, Mallo L, et al. Aryl hydrocarbon receptor-dependent enrich- ment of a megakaryocytic precursor with a high potential to produce proplatelets. Blood. 2016;127(18):2231-2240.
haematologica | 2019; 104(10)
2083